Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VisiCELL Medical is a private U.S. life science tools and healthcare technology company developing MRI-based in vivo cell-tracking analytics for the cell therapy field. Its core offering, VMI-Trac, is a cell-labeling and imaging platform designed to help developers monitor therapeutic immune and stem cells non-invasively across preclinical, translational, and clinical workflows. The company positions its technology as a "GPS for Cell Therapy," supporting applications in oncology, autoimmune disease, and regenerative medicine. Product variants are tailored for different cell types, including stem cells, NK cells, T cells, and CAR-T cells, and the company also provides consultation services around labeling and imaging strategy. VisiCELL Medical appears to operate primarily as a platform and tools company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VisiCELL Medical.